tiprankstipranks

Elizabeth Olek Insider Profile

4 Followers
Elizabeth Olek, SVP and CMO at Achillion Pharmaceuticals, holds 193.28K shares in Kronos Bio (Ticker: KRON), holds 2.00K shares in Achillion Pharmaceuticals (Ticker: ~ACHN). Most recently, Elizabeth Olek Sold ― shares of Kronos Bio on Feb 23, 2024 for an estimated value of 7.74K.
tipranks
Elizabeth Olek

Elizabeth Olek
Achillion Pharmaceuticals (~ACHN)
SVP and CMO

Not Ranked
Elizabeth Olek has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$185K
100.00%
A breakdown of Elizabeth Olek's holdings

Insider Roles

Kronos Bio
(KRON)
SR VP, CLINICAL SCIENCE
Roles that Elizabeth Olek holds in companies

Most Profitable Insider Trade

Stock:
Kronos Bio
(KRON)
Rating:Informative Sell
Date:Feb 23, 2024 - Today
Return:+10.50%
The most profitable trade made by Elizabeth Olek

Elizabeth Olek's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~ACHN
Achillion Pharmaceuticals
Jan 11, 2012
Uninformative Sell
125.43K
$13.52K
Kronos Bio
Feb 23, 2024
SR VP, CLINICAL SCIENCE
Informative Sell
7.74K
$184.96K
List of latest transactions for each holding click on a transaction to see Elizabeth Olek's performance on stock

Elizabeth Olek insider profile FAQ

What is the percentage of profitable transactions made by Elizabeth Olek?
The percentage of profitable transactions made by Elizabeth Olek is ―.
    What is the average return per transaction made by Elizabeth Olek?
    The average return per transaction made by Elizabeth Olek is ―.
      What stocks does Elizabeth Olek hold?
      Elizabeth Olek holds: ~ACHN, KRON stocks.
        What was Elizabeth Olek’s latest transaction?
        Elizabeth Olek latest transaction was an Informative Sell of $7.74K.
          What was Elizabeth Olek's most profitable transaction?
          Elizabeth Olek’s most profitable transaction was an Informative Sell of KRON stock on February 23, 2024. The return on the trade was 10.50%.
            What is Elizabeth Olek's role in Achillion Pharmaceuticals?
            Elizabeth Olek's role in Achillion Pharmaceuticals is SVP and CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.